Institutional investors purchased a net $264.8 thousand shares of INCY during the quarter ended September 2016 and now own 94.67% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MATRIX CAPITAL MANAGEMENT CO. LP Bought 800.0 Thousand shares of Incyte Corp
HEALTHCOR MANAGEMENT LP Bought 600.0 Thousand shares of Incyte Corp
VIKING GLOBAL INVESTORS LP Bought 503.6 Thousand shares of Incyte Corp